You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Selumetinib, Differentiated Thyroid Cancer , AZD6244

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage IIIB NSCLC AJCC v7, Stage IV NSCLC AJCC v7 Trial in Portland (Laboratory Biomarker Analysis, Paclitaxel, Pharmacological

Completed
  • Stage IIIB Non-Small Cell Lung Cancer AJCC v7
  • Stage IV Non-Small Cell Lung Cancer AJCC v7
  • Laboratory Biomarker Analysis
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 14, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston

Recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma Trial in Portland (procedure, drug,

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Triple-Negative Breast Carcinoma
  • Biopsy
  • +6 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 29, 2022

Malignant Peripheral Nerve Sheath Tumors, Neurofibromatosis 1 Trial in United States (Selumetinib, Sirolimus)

Active, not recruiting
  • Malignant Peripheral Nerve Sheath Tumors
  • Neurofibromatosis 1
  • Washington, District of Columbia
  • +4 more
Apr 1, 2022

NSCLC Trial in Boston, Durham (Osimertinib, Selumetinib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Boston, Massachusetts
  • +3 more
Aug 1, 2022

Uveal Melanoma Trial in New York, Houston (Selumetinib)

Active, not recruiting
  • Uveal Melanoma
  • New York, New York
  • +2 more
Jun 28, 2022

Malignant Tumor of Breast, Malignant Tumors of Digestive Organs, Malignant Tumors of Female Genital Organs Trial in Houston

Recruiting
  • Malignant Neoplasm of Breast
  • +4 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 29, 2021

Cancer, Non Small Cell Lung Cancer Trial in United Kingdom (Vandetanib, Selumetinib)

Completed
Has Results
  • Cancer
  • Non Small Cell Lung Cancer
  • Vandetanib, Selumetinib
  • Headington, Oxford, United Kingdom
  • +3 more
Sep 9, 2021

Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV Trial in Worldwide (Selumetinib 75 mg, Docetaxel 75

Completed
Has Results
  • Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
  • Selumetinib 75 mg
  • +3 more
  • Santa Monica, California
  • +50 more
Nov 22, 2022

Recurrent Low Grade Astrocytoma, Recurrent WHO Grade 2 Glioma, Refractory Low Grade Astrocytoma Trial in Canada, United States

Recruiting
  • Recurrent Low Grade Astrocytoma
  • +4 more
  • Quality-of-Life Assessment
  • +3 more
  • Birmingham, Alabama
  • +64 more
Aug 20, 2022

Biliary Tract Carcinoma, Gallbladder Carcinoma Trial in Toronto (Selumetinib, Cisplatin, Gemcitabine)

Active, not recruiting
  • Biliary Tract Carcinoma
  • Gallbladder Carcinoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 14, 2021

KRAS NP_004976.2:p.G12R, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7 Trial in United

Completed
Has Results
  • KRAS NP_004976.2:p.G12R
  • +2 more
  • Laboratory Biomarker Analysis
  • Selumetinib Sulfate
  • Los Angeles, California
  • +8 more
Jan 20, 2021

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, Adult, Acute Lymphoblastic Leukemia, Pediatric Trial in Denmark,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Copenhagen, Denmark
  • +16 more
Jan 26, 2022

Low Grade Glioma, Neurofibromatosis Type 1, Visual Pathway Glioma Trial in Canada, Puerto Rico, United States (Carboplatin,

Recruiting
  • Low Grade Glioma
  • +2 more
  • Birmingham, Alabama
  • +120 more
Jan 27, 2023

Breast Cancer Trial in Houston (Dasatinib, AZD6244)

Terminated
Has Results
  • Breast Cancer
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 1, 2020

Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland

Completed
Has Results
  • Refractory Differentiated Thyroid Gland Carcinoma
  • +4 more
  • Duarte, California
  • +32 more
Jun 24, 2021

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in San Francisco, Columbus

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +3 more
  • erlotinib hydrochloride
  • +2 more
  • San Francisco, California
  • +1 more
Jul 29, 2020

Borderline Ovarian Serous Tumor, Low Grade Ovarian Serous Adenocarcinoma, Micropapillary Serous Carcinoma Trial in United States

Completed
Has Results
  • Borderline Ovarian Serous Tumor
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Los Angeles, California
  • +48 more
Dec 2, 2020

Neurofibromatosis 1 (NF1), Plexiform Neurofibromas (PN) Trial run by the NCI (Selumetinib)

Active, not recruiting
  • Neurofibromatosis 1 (NF1)
  • Plexiform Neurofibromas (PN)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Aberdeen, United Kingdom
  • +24 more
Nov 2, 2021

Recurrent Endometrial Carcinoma, Recurrent Ovarian Carcinoma Trial (Biopsy, Biospecimen Collection, Bone Marrow Aspiration and

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • Recurrent Ovarian Carcinoma
  • Biopsy
  • +5 more
  • (no location specified)
Sep 29, 2022

Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV Trial in Worldwide (Selumetinib, Docetaxel, Placebo)

Active, not recruiting
Has Results
  • Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
  • Aurora, Colorado
  • +196 more
Dec 22, 2022

Non-Metastatic Adenocarcinoma of the Rectum Trial run by the NCI (Radiation Therapy, Capecitabine, AZD6244)

Terminated
Has Results
  • Non-Metastatic Adenocarcinoma of the Rectum
  • Radiation Therapy
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 1, 2021

Neurofibromatosis 1, Neurofibromatosis Type 1, NF1 Trial run by the National Cancer Institute (NCI) (AZD6244)

Active, not recruiting
  • Neurofibromatosis 1
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Neurofibromatosis 1, Plexiform Neurofibroma (PN) Trial in Worldwide (Selumetinib, Placebo)

Recruiting
  • Neurofibromatosis 1
  • Plexiform Neurofibroma (PN)
  • Gainesville, Florida
  • +40 more
Jan 16, 2023